Lab suppliers working to increase life science sales leads and sell lab equipment in Utah may be interested in Biotechnology Calendar, Inc.’s upcoming University of Utah life science marketing events. Our annual Salt Lake City BioResearch Product Faire™ Event is quickly approaching on August 15, 2013. Lab suppliers will find that the University of Utah has a great deal of funding available for lab supplies and other research needs.
Tags: 2013, Utah, university of utah, UUtah, UT, NIH funding, NSF funding
Tags: CA, University of California San Diego, 2013, California, SDVS, NIH funding, Lab Product Sales Event
Biotechnology Calendar, Inc.’s three back-to-back New York life science marketing events are quickly approaching starting October 1st, 2013, and they are the perfect opportunities for lab suppliers to market their university lab equipment and life science solutions. Our New York life science marketing events attracted 850 attendees last year. Of the attendees, 216 were purchasing agents, professors and post docs, and 83 were lab managers. The visitors represented 63 different research buildings and 153 departments across the three campuses. How many days of canvassing campuses would it take to visit over 150 research departments? These three life science marketing events introduce lab suppliers to hundreds of leads over the space of a few hours in just three days.
Tags: Rockefeller University, 2013, Columbia University, Stony Brook University, Columbia, RockU, NIH funding, SunySB
Lab suppliers in the Midwest interested in marketing university lab equipment and increasing lab sales leads may want to take note of Biotechnology Calendar, Inc.’s upcoming Ohio life science marketing events. Our annual Cincinnati Bioresearch Product Faire™ Event at the University of Cincinnati will be held on August 7, 2013 and spaces are filling up fast. Cincinnati is a very well-funded market that lab suppliers and biotechnology vendors may want to take advantage of.
Tags: 2013, Ohio, University of Cincinnati, UCinci, NIH funding
After the United States invested $14.5 billion in the Human Genome Project, the work has paid off with a $966 billion economic impact on the country and $59 billion in federal tax revenue. According to The News Journal, dozens of companies have used the information discovered in the project to develop new diagnostic tests and medicines based on gene variants connected to certain diseases. The Human Genome Project has triggered a “new era” in the life sciences, said Greg Lucier, CEO of Life Technologies Corp.
Tags: 2013, WashU, WUSTL, Washington State University, NIH funding